Edition:
United Kingdom

Aeglea Bio Therapeutics Inc (AGLE.OQ)

AGLE.OQ on NASDAQ Stock Exchange Global Market

9.89USD
23 May 2018
Change (% chg)

$-0.10 (-1.00%)
Prev Close
$9.99
Open
$9.94
Day's High
$10.54
Day's Low
$9.86
Volume
33,244
Avg. Vol
38,985
52-wk High
$11.19
52-wk Low
$2.81

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Mar '18 1.51 -0.487
FY 2017 Dec '17 1.48 -0.391
Sep '17 1.26 -0.480
Jun '17 1.48 -0.470
Mar '17 0.98 -0.467
FY 2016 Dec '16 1.25 -0.410
Sep '16 1.15 -0.468
Jun '16 1.37 -0.461
Mar '16 0.86 -0.398
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 4 1.72 2.37 1.50 0.00
Quarter Ending Sep-18 4 1.12 1.50 0.00 0.00
Year Ending Dec-18 4 5.47 6.01 3.88 0.57
Year Ending Dec-19 4 2.94 6.00 0.00 6.01
Earnings (per share)
Quarter Ending Jun-18 4 -0.36 -0.32 -0.40 -0.54
Quarter Ending Sep-18 4 -0.38 -0.33 -0.46 -0.54
Year Ending Dec-18 4 -1.60 -1.42 -1.76 -2.34
Year Ending Dec-19 5 -2.40 -1.43 -3.57 -2.70
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 84.06 32.75
P/E High - Last 5 Yrs. -- 293.32 45.73
P/E Low - Last 5 Yrs. -- 91.63 24.23
Beta -- 0.90 0.88
Price to Sales (TTM) 18.07 110.95 5.71
Price to Book (MRQ) 1.40 13.58 5.37
Price to Tangible Book (MRQ) 1.40 14.04 6.94
Price to Cash Flow (TTM) -- 71.44 23.33
% Owned Institutions 64.29 12.71 2.16

Dividends

  Company industry sector
Dividend Yield -- 0.31 1.50
Dividend Yield - 5 Year Avg -- 0.26 1.51
Dividend 5 Year Growth Rate -- 1.66 5.32
Payout Ratio(TTM) -- 15.72 43.29

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 7.72 399.27 9.21
Sales (TTM) vs TTM 1 Yr. Ago -0.67 78.86 5.69
Sales - 5 Yr. Growth Rate -- 32.18 10.32
EPS (MRQ) vs Qtr. 1 Yr. Ago -1.90 25.14 19.38
EPS (TTM) vs TTM 1 Yr. Ago -20.52 -- --
EPS - 5 Yr. Growth Rate -- 39.01 10.77
Capital Spending - 5 Yr. Growth Rate -- 40.31 15.47

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.81 2.19
Current Ratio (MRQ) 14.98 5.29 2.98
LT Debt to Equity (MRQ) 0.00 22.98 12.17
Total Debt to Equity (MRQ) 0.00 24.63 16.44
Interest Coverage (TTM) -- -99.39 32.81

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 40.04 54.45
Gross Margin - 5 Yr. Avg. -- 51.16 52.21
EBITD Margin (TTM) -508.77 -- --
EBITD - 5 Yr. Avg -- -575.09 10.96
Operating Margin (TTM) -512.56 -718.94 4.73
Operating Margin - 5 Yr. Avg. -- -596.41 6.40
Pre-Tax Margin (TTM) -506.49 -693.40 5.57
Pre-Tax Margin - 5 Yr. Avg. -- -599.76 6.82
Net Profit Margin (TTM) -506.49 -694.62 1.87
Net Profit Margin - 5 Yr. Avg. -- -602.62 3.09
Effective Tax Rate (TTM) -- 22.63 23.04
Effective Tax Rate - 5 Yr. Avg. -- 18.22 23.95

Efficiency

  Company industry sector
Revenue/Employee (TTM) 161,900 22,637,573 847,034,055
Net Income/Employee (TTM) -820,000 2,973,815 99,640,144
Receivable Turnover (TTM) 3.42 20.17 5.78
Inventory Turnover (TTM) -- 2.37 3.35
Asset Turnover (TTM) 0.07 0.39 0.92

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -34.06 -1.09 10.95
Return on Assets - 5 Yr. Avg. -- -0.58 12.32
Return on Investment (TTM) -36.00 1.57 14.38
Return on Investment - 5 Yr. Avg. -- 2.21 16.11
Return on Equity (TTM) -36.04 2.43 16.07
Return on Equity - 5 Yr. Avg. -- 3.09 17.39
  1 Year 3 Year 5 Year
Sales % -23.94 -- --
EPS (TTM) % -119.80 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Aeglea Bio Therapeutics Inc

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 51.56%
# of Holders: 50
Total Shares Held: 11,270,891
3 Mo. Net Change: 593,257
# New Positions: 12
# Closed Positions: 5
# Increased Positions: 30
# Reduced Positions: 6
# Net Buyers: 24
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.